The next generation of immunotherapy for cancer: Small molecules could make big waves

William G. Kerr, John D Chisholm

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

After decades of intense effort, therapeutics that leverage the immune system to fight cancer have now been conclusively demonstrated to be effective. Immuno-oncology has arrived and will play a key role in the treatment of cancer for the foreseeable future. However, the search for novel methods to improve immune responses to cancer continues unabated. Toward this end, small molecules that can either reduce immune suppression in the tumor milieu or enhance activation of cytotoxic lymphocyte responses to the tumor are actively being pursued. Such novel treatment strategies might be used as monotherapies or combined with other cancer therapies to increase and broaden their efficacy. In this article, we provide an overview of small molecule immunotherapeutic approaches for the treatment of cancer. Over the next decade and beyond, these approaches could further enhance our ability to harness the immune system to combat cancer and thus become additional weapons in the oncologist's armory.

Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalJournal of Immunology
Volume202
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Immunotherapy
Neoplasms
Immune System
Therapeutics
Weapons
Lymphocyte Activation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The next generation of immunotherapy for cancer : Small molecules could make big waves. / Kerr, William G.; Chisholm, John D.

In: Journal of Immunology, Vol. 202, No. 1, 01.01.2019, p. 11-19.

Research output: Contribution to journalReview article

@article{a04ebf15a0b9467e98aae1b20fbb2bbb,
title = "The next generation of immunotherapy for cancer: Small molecules could make big waves",
abstract = "After decades of intense effort, therapeutics that leverage the immune system to fight cancer have now been conclusively demonstrated to be effective. Immuno-oncology has arrived and will play a key role in the treatment of cancer for the foreseeable future. However, the search for novel methods to improve immune responses to cancer continues unabated. Toward this end, small molecules that can either reduce immune suppression in the tumor milieu or enhance activation of cytotoxic lymphocyte responses to the tumor are actively being pursued. Such novel treatment strategies might be used as monotherapies or combined with other cancer therapies to increase and broaden their efficacy. In this article, we provide an overview of small molecule immunotherapeutic approaches for the treatment of cancer. Over the next decade and beyond, these approaches could further enhance our ability to harness the immune system to combat cancer and thus become additional weapons in the oncologist's armory.",
author = "Kerr, {William G.} and Chisholm, {John D}",
year = "2019",
month = "1",
day = "1",
doi = "10.4049/jimmunol.1800991",
language = "English (US)",
volume = "202",
pages = "11--19",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - The next generation of immunotherapy for cancer

T2 - Small molecules could make big waves

AU - Kerr, William G.

AU - Chisholm, John D

PY - 2019/1/1

Y1 - 2019/1/1

N2 - After decades of intense effort, therapeutics that leverage the immune system to fight cancer have now been conclusively demonstrated to be effective. Immuno-oncology has arrived and will play a key role in the treatment of cancer for the foreseeable future. However, the search for novel methods to improve immune responses to cancer continues unabated. Toward this end, small molecules that can either reduce immune suppression in the tumor milieu or enhance activation of cytotoxic lymphocyte responses to the tumor are actively being pursued. Such novel treatment strategies might be used as monotherapies or combined with other cancer therapies to increase and broaden their efficacy. In this article, we provide an overview of small molecule immunotherapeutic approaches for the treatment of cancer. Over the next decade and beyond, these approaches could further enhance our ability to harness the immune system to combat cancer and thus become additional weapons in the oncologist's armory.

AB - After decades of intense effort, therapeutics that leverage the immune system to fight cancer have now been conclusively demonstrated to be effective. Immuno-oncology has arrived and will play a key role in the treatment of cancer for the foreseeable future. However, the search for novel methods to improve immune responses to cancer continues unabated. Toward this end, small molecules that can either reduce immune suppression in the tumor milieu or enhance activation of cytotoxic lymphocyte responses to the tumor are actively being pursued. Such novel treatment strategies might be used as monotherapies or combined with other cancer therapies to increase and broaden their efficacy. In this article, we provide an overview of small molecule immunotherapeutic approaches for the treatment of cancer. Over the next decade and beyond, these approaches could further enhance our ability to harness the immune system to combat cancer and thus become additional weapons in the oncologist's armory.

UR - http://www.scopus.com/inward/record.url?scp=85059238028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059238028&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1800991

DO - 10.4049/jimmunol.1800991

M3 - Review article

C2 - 30587569

AN - SCOPUS:85059238028

VL - 202

SP - 11

EP - 19

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -